C
C4 Therapeutics, Inc.
CCCC · NASDAQ · Healthcare · 469M
Closing price
$3.16
+10.88% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.0×
Enterprise value / EBITDAEV/EBITDA
-2.4×
Free cash flow yieldFCF yield
-37.9%
Return on equityROE
-40.9%
Operating margin
-290.7%
Net debt / EBITDAbalance-sheet strength
0.1×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.